IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BATTEZZATI, PIER MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.287
NA - Nord America 8.965
AS - Asia 7.330
SA - Sud America 739
AF - Africa 143
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 4
Totale 27.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.610
GB - Regno Unito 4.559
CN - Cina 2.335
SG - Singapore 2.078
IT - Italia 1.759
RU - Federazione Russa 783
DE - Germania 763
HK - Hong Kong 735
SE - Svezia 610
BR - Brasile 546
BD - Bangladesh 457
FR - Francia 452
VN - Vietnam 374
IN - India 324
TR - Turchia 285
NL - Olanda 256
KR - Corea 240
CA - Canada 239
UA - Ucraina 210
IE - Irlanda 200
FI - Finlandia 181
JP - Giappone 137
ES - Italia 128
EU - Europa 109
ID - Indonesia 101
GR - Grecia 73
DK - Danimarca 71
PL - Polonia 64
CO - Colombia 53
AR - Argentina 50
MX - Messico 49
CI - Costa d'Avorio 44
AT - Austria 32
AU - Australia 26
IQ - Iraq 25
PK - Pakistan 25
PH - Filippine 24
BE - Belgio 21
EC - Ecuador 21
MY - Malesia 21
SA - Arabia Saudita 21
ZA - Sudafrica 21
IL - Israele 18
NO - Norvegia 18
CR - Costa Rica 17
RO - Romania 17
UZ - Uzbekistan 17
PE - Perù 16
VE - Venezuela 16
AE - Emirati Arabi Uniti 15
CL - Cile 13
TH - Thailandia 13
EG - Egitto 12
PT - Portogallo 12
TW - Taiwan 12
CH - Svizzera 11
HR - Croazia 11
KZ - Kazakistan 11
CZ - Repubblica Ceca 10
PY - Paraguay 10
JM - Giamaica 9
KE - Kenya 9
MA - Marocco 9
DZ - Algeria 8
HN - Honduras 8
HU - Ungheria 8
JO - Giordania 8
SK - Slovacchia (Repubblica Slovacca) 8
TN - Tunisia 8
BG - Bulgaria 7
NG - Nigeria 7
OM - Oman 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
CY - Cipro 6
IR - Iran 6
NP - Nepal 6
AL - Albania 5
BO - Bolivia 5
ET - Etiopia 5
LK - Sri Lanka 5
LV - Lettonia 5
BB - Barbados 4
KG - Kirghizistan 4
LY - Libia 4
PR - Porto Rico 4
SN - Senegal 4
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SC - Seychelles 3
SV - El Salvador 3
BN - Brunei Darussalam 2
BW - Botswana 2
BY - Bielorussia 2
DJ - Gibuti 2
DO - Repubblica Dominicana 2
Totale 27.568
Salva come PNG Salva come JPEG
Città #
Southend 4.201
Houston 1.423
Singapore 1.215
Ashburn 746
Hong Kong 696
Milan 591
Ann Arbor 555
San Jose 444
Beijing 415
Chandler 411
Dallas 341
Seattle 298
Princeton 256
Wilmington 249
Council Bluffs 245
Santa Clara 223
Los Angeles 206
Dublin 198
New York 173
Hefei 148
Fairfield 147
Bengaluru 136
Dearborn 133
Redmond 133
Jacksonville 130
Lauterbourg 124
Frankfurt am Main 122
Toronto 119
Buffalo 117
Ho Chi Minh City 117
Nanjing 110
Guangzhou 104
Shanghai 100
Des Moines 98
Moscow 97
Woodbridge 96
Hanoi 95
Grafing 87
Rome 87
Sakarya 87
Mountain View 83
Boardman 79
Jinan 72
Tokyo 72
Berlin 68
Cambridge 66
Jakarta 60
Munich 60
Serra 60
Helsinki 59
São Paulo 58
Cangzhou 51
Columbus 50
Redwood City 50
Shenyang 50
Andover 47
Changsha 47
Somerville 47
London 46
Warsaw 45
Seoul 44
Abidjan 43
Bogotá 42
Tianjin 41
Florence 40
Hangzhou 38
The Dalles 37
Athens 35
Zhengzhou 35
Naples 33
San Diego 33
Shenzhen 32
Phoenix 31
Nanchang 30
Hebei 29
Istanbul 27
San Francisco 27
Boston 26
Madrid 26
Wuhan 25
Fuzhou 24
Saint Petersburg 24
Manchester 23
Paris 23
Turin 23
Bologna 22
Falls Church 22
Belo Horizonte 21
Montreal 21
Nuremberg 21
Orem 21
Chicago 20
Mumbai 20
Silver Spring 20
Amsterdam 19
Haiphong 19
Ningbo 19
Bitonto 18
Jiaxing 18
Brooklyn 17
Totale 17.532
Salva come PNG Salva come JPEG
Nome #
Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic Fatty liver disease 1.652
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis 987
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history 592
Effects of Age and Sex of on Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients with Primary Biliary Cholangitis 513
CA.ME.LI.A. An epidemiological study on the prevalence of cardiovascular, metabolic, liver and autoimmune diseases in Northern Italy 437
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 368
X chromosome monosomy : a common mechanism for autoimmune diseases 366
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 359
Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis 351
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 323
Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status 298
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis 297
X monosomy in female systemic lupus erythematosus 291
ABCB4 mutations in adult patients with cholestatic liver disease : impact and phenotypic expression 279
Uno studio longitudinale sull’incidenza di eventi cardiovascolari in una popolazione del nord Italia 278
Acute liver and renal failure during treatment with buprenorphine at therapeutic dose 277
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis 269
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis 266
Antibodies to carbonic anhydrase II in antimitochondrial antibody-negative primary biliary cirrhosis: a negative study 266
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 264
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival 262
Spontaneous hypoglycemia in patients with cystic fibrosis 262
Frequency of monosomy X in women with primary biliary cirrhosis 261
T-cell receptor polymorphism in primary biliary cirrhosis 258
Incidence and Impact of Decompensating Events in Primary Biliary Cirrhosis : Results of an International Follow Up Study of 3030 Patients 255
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 255
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis 254
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis 248
Severe azathioprine-induced liver injury 22 months after initiation of treatment 247
Sieroepidemiologia delle epatiti virali a trasmissione enterica (HAV e HEV) in Italia: progetto CAMELIA 244
Reduced insulin secretion during OGTT is tightly related to subsequent development of cystic fibrosis related diabetes 237
Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions 233
Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients 232
Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis 231
Collecting stories of illness experience. An undergraduate medical curriculum to develop connectedness and togetherness with patients 231
Infermieristica clinica in medicina interna 230
Blood fetal microchimerism in primary biliary cirrhosis 230
Genetic variants of the endothelial nitric oxide synthase in patients with primary biliary cirrhosis: Association with disease severity 229
The Relationship of Glucose Intolerance/Diabetes and Overweight/Obesity with Sphingolipidoma Alterations 224
Insulin secretory defects identified from OGTT modelling are related to subsequent diabetes and worse pulmonary function in CF patients 224
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 223
[Reynolds syndrome. First Italian epidemiologic data] 222
Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population. CA.ME.LI.A study 7 year follow-up 219
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial 211
Age- and sex-dependent distribution of OGTT-related variables in a population of cystic fibrosis patients 211
Insulin secretion, nutritional status and respiratory function in cystic fibrosis patients with normal glucose tolerance 209
Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study 207
La formazione alle soft skills nel Corso di laurea in Medicina : uno studio qualitativo sulle scritture riflessive di un campione di studenti 204
Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction 202
EFFECT OF EARLY DERANGEMENTS IN GLUCOSE TOLERANCE MECHANISMS ON THE NUTRITIONAL STATUS AND RESPIRATORY FUNCTION OF CYSTIC FIBROSIS PATIENTS 201
Liver involvement in cystic fibrosis : primary organ damage or innocent bystander? 199
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex : Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 199
Effects of a preparation containing a standardized ginseng extract combined with trace elements and multivitamins against hepatotoxin-induced chronic liver disease in the elderly 195
Intraductal ultrasound for the evaluation of patients with biliary strictures and no abdominal mass on computed tomography 190
Vaccines in the 21st century: the genetic response and the innocent bystander 189
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy 189
A longitudinal study on the incidence of cardiovascular events in a population of Northern Italy 188
PBC screen : an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis 186
Caratterizzazione della "diabesità" in una popolazione del nord Italia: un'analisi epidemiologica 182
Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon 182
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls 181
Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion 181
Antibodies to hepatitis C virus in primary biliary cirrhosis 180
Role of ABCB4 gene mutations in hepatobiliary diseases of the adult : the experience of a liver Unit in Milan 178
Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis 178
Is autoimmunity a matter of sex? 178
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome 178
Prognostic value of C-reactive protein in patients with stress induced myocardial ischemia 177
Role of ABCB4 gene in liver diseases 175
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 173
Which images do medical students draw to discuss their early clinical experience, in reflection meetings? 171
Learning to grasp the emotional dimensions of clinical practice and their powerful meaning : a study on how medical students’ report patients’ grief in their reflective writings 170
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients 169
Rischio clinico da farmaci 168
Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis 167
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 167
Ursodeoxycholic acid for liver disease associated to cystic fibrosis: long-term follow-up of patients enrolled in the Italian multicenter trial 163
Effect of different doses of ursodeoxycholic acid in chronic liver disease 160
Clinical features and management of primary biliary cirrhosis 159
Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation. A controlled longitudinal study 157
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies 155
Primary Biliary Cholangitis at a Young Age : Clinical Characteristics and Prognosis 155
Ursodeoxycholic acid for chronic liver diseases 153
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis 152
Lack of association between circulating HCV-RNA and anti-HCV positivity in primary biliary cirrhosis 151
Acupuncture for paroxysmal and persistent atrial fibrillation : An effective non-pharmacological tool? 149
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study 145
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration 144
Storie di bevitori passivi: un progetto di formazione dei medici per favorire l'inclusione e la tutela del diritto alla salute 143
Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome 142
Complement system is not activated in primary biliary cirrhosis 140
Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma 139
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis 139
Increase in age at diagnosis of Primary Biliary Cholangitis over the last 40 years 137
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool 137
MMP-1 and MMP-3 polymorphism and arrhythmia recurrence after electrical cardioversion in patients with persistent atrial fibrillation 136
Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis 135
Efficacy of acupuncture in preventing atrial fibrillation recurrences after electrical cardioversion 134
Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study 133
Novel soy germ pasta improves endothelial function, blood pressure, and oxidative stress in patients with type 2 diabetes 133
Totale 23.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.243
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.974 172 151 119 178 122 123 151 105 217 188 157 291
2022/20231.754 226 154 125 204 200 301 50 96 158 92 91 57
2023/20241.472 66 157 126 94 300 87 81 103 43 79 157 179
2024/20253.633 160 327 152 388 258 186 198 342 228 365 334 695
2025/20268.093 671 493 893 556 768 519 997 471 763 542 748 672
2026/2027287 287 0 0 0 0 0 0 0 0 0 0 0
Totale 28.643